Inspira Tech Partners With Zriha Medical for New Production Line
Ticker: IINNW · Form: 6-K · Filed: Jan 17, 2025 · CIK: 1837493
Sentiment: neutral
Topics: collaboration, medical devices, production
TL;DR
Inspira Tech teams up with Zriha Medical to build a new production line for advanced medical devices.
AI Summary
On January 17, 2025, Inspira Technologies Oxy B.H.N. Ltd. announced a collaboration with Zriha Medical to launch a new production line. This partnership aims to develop and produce cutting-edge medical devices, leveraging Inspira's technology and Zriha's manufacturing expertise.
Why It Matters
This collaboration could expand Inspira's product offerings and manufacturing capabilities, potentially leading to increased revenue and market share in the medical device sector.
Risk Assessment
Risk Level: medium — The success of this collaboration depends on the effective integration of technologies and market acceptance of the new products, introducing execution and market risks.
Key Players & Entities
- Inspira Technologies Oxy B.H.N. Ltd. (company) — Registrant
- Zriha Medical (company) — Collaborator
- January 17, 2025 (date) — Announcement Date
FAQ
What is the primary goal of the collaboration between Inspira Technologies and Zriha Medical?
The primary goal is to launch a cutting-edge production line for medical devices.
What type of filing is this report?
This is a Form 6-K report of a foreign private issuer.
When was the press release announcing this collaboration issued?
The press release was issued on January 17, 2025.
What is the SIC code for Inspira Technologies Oxy B.H.N. Ltd.?
The SIC code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Where is Inspira Technologies Oxy B.H.N. Ltd. located?
The company's principal executive office is located at 2 Ha-Tidhar St., Ra'anana, 4366504, Israel.
Filing Stats: 293 words · 1 min read · ~1 pages · Grade level 9 · Accepted 2025-01-17 08:50:02
Filing Documents
- ea0228007-6k_inspira.htm (6-K) — 12KB
- ea022800701ex99-1_inspira.htm (EX-99.1) — 8KB
- 0001213900-25-004363.txt ( ) — 21KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inspira Technologies Oxy B.H.N. Ltd. Date: January 17, 2025 By: /s/ Dagi Ben-Noon Name: Dagi Ben-Noon Title: Chief Executive Officer 2